EPISODE · Jan 4, 2024 · 26 MIN
Natural Products: The Next Frontier in Drug Discovery
from omg OMx Podcast
In this episode of the omg OMx podcast, Pelle Simpson, Senior Scientist at Enveda Biosciences, joins us to share his experiences and how Enveda Biosciences is using natural products to shape drug discovery.00:39 - Introduction: Pelle's diverse background, from analytical chemistry to 3D printing, electrical engineering to how he joined Enveda Biosciences 03:18 - Pelle's "OMG" moment: How he got started in natural products drug discovery05:25 - The significance of Enveda Biosciences within the natural products landscape07:44 - The role of mass spectrometry and high-throughput screening in drug discovery11:03 - The diverse sample sources of medicinal plants for research and how Enveda Biosciences expands their library12:10 - The humble beginnings of Enveda Biosciences: : The CEO's personal experience with herbal medicine and the potential of natural products13:28 - How Pelle's educational and experiential background influences his work and shaped his approach to industrializing natural products drug discovery.18:04 - The parallels and differences between academia and industry, and how Enveda Biosciences combines the best of both worlds19:35 - The art of balancing diverse projects20:40 - Overcoming innovation blocks, staying inspired and refocused21:54 - Enveda's strategy of internalizing various aspects natural products space, and what other factors are needed for long-term success23:48 – 3D printing skills showdown: Kate's timsTOF SCP vs. Pelle's student's ubiquitin protein structure.Connect with Pelle Simpson on LinkedInExplore Enveda BiosciencesDon't forget to like, share, and subscribe for the latest episodes of omg OMx, where we humanize science and get inspired by scientists around the globe. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Natural Products: The Next Frontier in Drug Discovery
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m